TBG Diagnostics Ltd TDLAF:OTCQB

RT Quote | Exchange | USD
Last | 02/25/21 EST
0.1085UNCH (UNCH)
Volume
50
52 week range
0.01 - 0.50

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.1085
  • 52 Week High0.50
  • 52 Week High Date03/13/20
  • 52 Week Low0.01
  • 52 Week Low Date02/27/20
  • Market Cap23.61M
  • Shares Out217.59M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.02
  • 1 Year % Change697.79

RATIOS/PROFITABILITY

  • EPS (TTM)-0.03
  • P/E (TTM)-3.11
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-1.103M
  • ROE (MRQ)-69.94%
  • Revenue (MRQ)2.97M
  • Gross Margin (MRQ)72.84%
  • Net Margin (MRQ)-291.30%
  • Debt To Equity (MRQ)25.45%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest TBG Diagnostics Ltd News

There is no recent news for this security.

Latest TDLAF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
TBG Diagnostics Limited, formerly Progen Pharmaceuticals Limited, is a biotechnology company. The Company's principal activities include the discovery, research and development of pharmaceutical therapeutics for the treatment of human diseases, and the provision of contract services related to the process development, manufacture and quality assurance of biopharmaceutical products. The Company's segments include Research & Development, and Manufacturing. The Company is...
Indrajit Arulampalam
Chairman
Willy Hsu
Chief Operating Officer
Address
U 6 138 Juliette Street, Greenslopes
Brisbane, QLD
4120
Australia